# SEG P0 Independent Review Execution Report

**Document ID:** `SEG_P0_INDEPENDENT_REVIEW_EXECUTION_REPORT`  
**Mode:** `CONTROLLED REVIEW EXECUTION`  
**Scope:** Drug HTML, OSCE Atlas package, and PreTest content artifacts.  
**Overall review outcome:** `REVIEW_BLOCKED_PENDING_EVIDENCE`  
**Final report status:** `SEG_P0_INDEPENDENT_REVIEW_EXECUTION_COMPLETE`

## 1. Executive determination

This controlled pass executed the documented **review-preparation and evidence-assessment activities** for the three P0 internally owned assets. It did not perform or simulate a qualified clinical review, Pharmacology/Drug Safety review, visual review, accessibility review, Assessment Quality review, technical review, rights review, or source-level approval. No reviewer identities, credentials, review dates, findings, or conclusions were invented.

All three sources remain blocked because authoritative identity/version, provenance, rights, and independent review evidence remain incomplete. The internal ownership declaration permits controlled SEG management of the retained artifacts as `SEG_INTERNAL_ASSET`; it does not certify clinical accuracy, completeness, educational suitability, rights clearance, or production readiness.[1] [2]

```text
APPROVED_SOURCES = NONE
NORMALIZATION = BLOCKED_PENDING_APPROVED_SOURCE
P0_DECISIONS = NO_AUTOMATIC_APPROVAL
```

## 2. Consolidated source review results

| Source | Review performed | Evidence available | Issues found | Remaining blockers | Next decision |
|---|---|---|---|---|---|
| Drug HTML | Read-only review preparation against the exact retained HTML, version register, audit trail, and assigned Emergency Medicine and Pharmacology/Drug Safety roles. Clinical accuracy and drug-safety questions were defined; no medical conclusion was issued. | UTF-8 HTML, 25,918 bytes, 394 lines, SHA-256 `5367711d08df2393cf852815b1b9d0ad4dac8240ac061cd88c71a53884e938ac`; internal title signal; 47 observed `drugList` entities; artifact-level continuity | Canonical source/title, publisher/owner, version/date, original locator, extraction lineage, rights, and current-protocol evidence are unresolved. The observed absence of an explicit interaction table is not a clinical conclusion. | Independent Emergency Medicine review; Pharmacology/Drug Safety review; technical HTML/lineage review; rights/provenance evidence; version and audit-event closure | `REVIEW_BLOCKED_PENDING_EVIDENCE` |
| OSCE Atlas package | Read-only package/inventory review preparation against the exact recovered package and assigned Emergency Medicine, Visual, and Accessibility roles. Image inventory, alt-text, clinical-labeling, and educational-suitability requirements were defined; no image or clinical label was changed. | Target `ATLAS_ASSET_OSCE_VISUAL_001`; inner and outer package hashes; 14 PNG members with per-file hashes; one station-text file; one validation-notes file; limited readability notes for two selected images | Authoritative PDF/title/owner/version/date, per-image lineage, text/image rights, complete visual evidence, alt-text/accessibility evidence, clinical labeling validation, and educational-suitability decision are unresolved. Only two images have limited readability notes. | Independent Emergency Medicine review; full Visual review; full Accessibility review; technical/provenance/rights review; authoritative source and version evidence; audit-event closure | `REVIEW_BLOCKED_PENDING_EVIDENCE` |
| PreTest content artifacts | Read-only review preparation against the exact `UPD811-007` representation and assigned Emergency Medicine and Assessment Quality roles. Question-completeness, answer-key, explanation, OCR, and metadata review questions were defined; no text or question was corrected. | `pretestnew_Study_Guide_UTF8.txt`; 131,490 bytes; 1,349 logical lines; SHA-256 `b4ba84879b1247b9aaeb6172c6dffcb7dcc0860f8894e4651b2bc8a9fd669166`; registry continuity; known OCR/extraction corruption recorded | Authoritative PDF/equivalent, canonical identity/version/date/locator, immutable comparison, completeness/numbering baseline, answer-key inventory, explanation inventory, rights, provenance, and review evidence are unresolved. Answer-key and explanation availability were not inferred from the absence of evidence. | Authoritative comparison and OCR reconciliation; independent Emergency Medicine review; Assessment Quality review; technical/OCR, rights, provenance, version, and audit-event closure | `REVIEW_BLOCKED_PENDING_EVIDENCE` |

## 3. Drug HTML review status

The Drug HTML review preparation confirms that the exact retained representation can be identified by its recorded hash and basic structure. The required Emergency Medicine and Pharmacology/Drug Safety review streams are prepared but have not been completed. The clinical review must evaluate indications, dose statements, contraindications, clinical context, currency, omissions, ambiguity, and conflicts. The drug-safety review must separately evaluate drug identity, dosing, interactions, contraindications, safety signals, omissions, and the limits of the represented interaction information.

The canonical source identity, version/date, original locator, extraction history, rights, and independent reviewer evidence remain unavailable. The next permitted step is evidence closure and role-based review against the unchanged exact artifact. The decision remains `REVIEW_BLOCKED_PENDING_EVIDENCE`.[3]

## 4. OSCE Atlas review status

The OSCE Atlas review preparation confirms the recovered package inventory and per-file byte-level evidence for 14 PNG members. It defines independent medical, visual, and accessibility review requirements. Medical review must assess image-to-caption/station correspondence, clinical labeling, educational synthesis, current-protocol alignment, domain-specific concerns, ambiguity, and source-page fidelity. Visual review must assess all 14 members for legibility, labels, annotations, reproducibility, contrast, visual defects, and source context. Accessibility review must assess meaningful alt-text or equivalent descriptions, captions, clinical labels, legibility, contrast, non-color dependence, semantics, assistive-technology behavior, and language/localization requirements.

The validation notes establish limited readability evidence for only two selected images and do not close the complete visual or accessibility gates. The authoritative source, rights, image lineage, clinical decision, educational-suitability decision, and independent review records remain unavailable. The decision remains `REVIEW_BLOCKED_PENDING_EVIDENCE`.[4]

## 5. PreTest review status

The PreTest review preparation confirms the recovered `UPD811-007` representation and records the known OCR/extraction corruption without correcting it. The Assessment Quality review must independently establish question completeness, numbering, answer-key availability, explanation/rationale linkage, ambiguity, assessment alignment, and fidelity to the authoritative source. The Emergency Medicine review must assess clinical currency, answer integrity, rationale fidelity, unsafe ambiguity, and unresolved conflicts after the authoritative comparison and OCR reconciliation are complete.

The current evidence does not establish whether every question has an answer key or explanation; these remain `NOT_AVAILABLE` in the reviewed evidence rather than negative findings. The authoritative PDF/equivalent, version, rights, provenance, comparison baseline, completeness/numbering evidence, and reviewer records remain unavailable. The decision remains `REVIEW_BLOCKED_PENDING_EVIDENCE`.[5]

## 6. Cross-source evidence and governance blockers

| Gate | Drug HTML | OSCE Atlas | PreTest |
|---|---|---|---|
| Retained artifact identity | `CONFIRMED` at representation level | `CONFIRMED` for recovered package/member inventory | `CONFIRMED` for `UPD811-007` representation |
| Canonical source identity/version | `NOT_AVAILABLE` / partial title signal only | `NOT_AVAILABLE` | `NOT_AVAILABLE` |
| Provenance and lineage | Partial artifact continuity; authoritative chain open | Package continuity; source-to-image/text chain open | Recovery continuity; authoritative comparison and OCR chain open |
| Rights/license | `NOT_AVAILABLE` | `NOT_AVAILABLE` | `NOT_AVAILABLE` |
| Required independent review | `PENDING_REVIEW` | `PENDING_REVIEW` | `PENDING_REVIEW` |
| Named reviewer evidence | `NOT_SUPPLIED` | `NOT_SUPPLIED` | `NOT_SUPPLIED` |
| Version/audit closure | Pending | Pending | Pending |
| Current review outcome | `REVIEW_BLOCKED_PENDING_EVIDENCE` | `REVIEW_BLOCKED_PENDING_EVIDENCE` | `REVIEW_BLOCKED_PENDING_EVIDENCE` |

These blockers are governance findings, not clinical judgments. No source is promoted because artifact hashes, package inventories, internal ownership, or review preparation cannot substitute for source authority, version control, rights evidence, independent review, or approval.[1] [2]

## 7. Required next actions

The next permitted actions are limited to evidence acquisition, version closure, audit-trail completion, authorized reviewer appointment, and independent role-based review preparation or execution against exact immutable artifacts. Future review records must include the artifact hash, source/version, reviewer role and authorized identity, date/time, exact locators, findings, conflicts, unresolved issues, disposition, and append-only audit event.

No source may be set to `READY_FOR_NORMALIZATION` from this report. A source may progress only after its independent evidence, medical/role-based review, rights, version, provenance, audit, and applicable technical/visual/accessibility/assessment gates are separately documented and approved through the existing governance process.

## 8. Explicit non-actions

| Action | Result |
|---|---|
| Qualified clinical review performed by this task | `false` |
| Pharmacology/Drug Safety review performed by this task | `false` |
| Visual or Accessibility review completed by this task | `false` |
| Assessment Quality review completed by this task | `false` |
| Clinical correctness certified | `false` |
| Source approval granted | `false` |
| `READY_FOR_NORMALIZATION` set | `false` |
| Content Records created | `false` |
| Zod/Prisma/SQL/schema work performed | `false` |
| Database import executed | `false` |
| Normalization performed | `false` |
| Activation or publication performed | `false` |
| Source Registry approval state changed | `false` |
| Source artifacts modified or OCR corrected | `false` |

## 9. Final governance state

| Control | Current state |
|---|---|
| Ownership classification | `SEG_INTERNAL_ASSET` for the declared retained artifact scopes |
| P0 review outcomes | All three: `REVIEW_BLOCKED_PENDING_EVIDENCE` |
| Source approvals | `APPROVED_SOURCES = NONE` |
| Normalization | `BLOCKED_PENDING_APPROVED_SOURCE` |
| Source Registry | Unchanged |
| Medical/rights/technical/visual/accessibility/assessment approvals | Not granted |
| Next allowed phase | Independent evidence closure and role-based review only |

## 10. Final status

`SEG_P0_INDEPENDENT_REVIEW_EXECUTION_COMPLETE`

This final status confirms completion of the controlled review-execution report. It does not mean that any P0 source is review-complete, clinically validated, rights-cleared, approved, normalized, imported, activated, or published.

## References

[1]: file:///home/ubuntu/seg-internship-output/SEG_INTERNAL_OWNERSHIP_DECLARATION_v1.md "SEG Internal Ownership Declaration v1"

[2]: file:///home/ubuntu/seg-internship-output/SEG_P0_REVIEW_ASSIGNMENT_MATRIX.md "SEG P0 Review Assignment Matrix"

[3]: file:///home/ubuntu/seg-internship-output/SEG_DRUG_HTML_REVIEW_STATUS_v1.md "SEG Drug HTML Review Status v1"

[4]: file:///home/ubuntu/seg-internship-output/SEG_OSCE_ATLAS_REVIEW_STATUS_v1.md "SEG OSCE Atlas Review Status v1"

[5]: file:///home/ubuntu/seg-internship-output/SEG_PRETEST_REVIEW_STATUS_v1.md "SEG PreTest Review Status v1"

[6]: file:///home/ubuntu/seg-internship-output/SEG_P0_VERSION_CONTROL_REGISTER.md "SEG P0 Version Control Register"

[7]: file:///home/ubuntu/seg-internship-output/SEG_P0_AUDIT_TRAIL_REGISTER.md "SEG P0 Audit Trail Register"

[8]: file:///home/ubuntu/seg-internship-output/SEG_SOURCE_CLOSURE_DECISION_QUEUE.md "SEG Source Closure Decision Queue"

**Document status:** `CONSOLIDATED_REVIEW_BLOCKED_PENDING_EVIDENCE`
